PR Newswire·May 27, 2026, 4:30 PM ET

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

Azitra Inc. (NYSE American: AZTR) announced it will convene its 2026 Annual Meeting on June 4, 2026, at 11:00 a.m. ET, then immediately adjourn without conducting business due to a minor administrative mailing delay.
The meeting will reconvene as the "Reconvened 2026 Annual Meeting" on June 15, 2026, at 11:00 a.m. ET in a virtual format.
Stockholders may vote or submit questions during the webcast at www.proxydocs.com/AZTR using the control number from their proxy card.
Eligible stockholders as of the April 24, 2026 record date are urged to vote their proxies no later than June 15, 2026, at 10:59 a.m. ET.
Voting methods include mailing the proxy card, submitting via the internet at www.proxypush.com/AZTR, or voting by telephone.
Azitra's lead program ATR-12 targets Netherton syndrome using an engineered strain of S. epidermidis, while program ATR-04 targets EGFR inhibitor-associated rash with FDA Fast Track designation.
The company utilizes a proprietary platform of engineered proteins, topical live biotherapeutic products, & artificial intelligence to screen approximately 1,500 bacterial strains.